Back to Search
DHARMRAJ CHAUHAN, M.D.
M.D.
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
NPI: 1568775096IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery Physician
Surgery
Code: 208600000X
25MA09711700(NJ)
Thoracic Surgery (Cardiothoracic Vascular Surgery) PhysicianPrimary
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Code: 208G00000X
036139891(IL)R7415(TX)
CMS Specialties
PrimaryTHORACIC SURGERY
Education
OTHER
Class of 2010
Research & Publications (20)
Association of mutations in rpsL gene with high degree of streptomycin resistance in clinical isolates of Mycobacterium tuberculosis in India.
PMID 19287069·Indian J Med Res·2009
8-other
In vitro effect of fluoroquinolones against Mycobacterium tuberculosis isolates from Agra & Kanpur region of north India.
PMID 19675382·Indian J Med Res·2009
4-observational
Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor.
PMID 19540748·Eur J Cancer·2009
8-other
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
PMID 19369963·Leukemia·2009
7-preclinical
Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.
PMID 19436050·Blood·2009
7-preclinical
Identification of environmental mycobacteria isolated from Agra, north India by conventional & molecular approaches.
PMID 19535838·Indian J Med Res·2009
8-other
Visual format for detection of Mycobacterium tuberculosis and M. bovis in clinical samples using molecular beacons.
PMID 19661384·J Mol Diagn·2009
8-other
Bone marrow microenvironment and the identification of new targets for myeloma therapy.
PMID 18843284·Leukemia·2009
6-review
Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implications.
PMID 19270264·Blood·2009
8-other
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma.
PMID 19151776·Leukemia·2009
7-preclinical
Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo.
PMID 19139110·Mol Cancer Ther·2009
7-preclinical
Ground water geochemistry of Ballia district, Uttar Pradesh, India and mechanism of arsenic release.
PMID 19135229·Chemosphere·2009
8-other
Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India.
PMID 19112008·Int J Antimicrob Agents·2009
8-other
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.
PMID 19417213·Blood·2009
7-preclinical
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling.
PMID 19018094·Blood·2009
8-other
Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomib.
PMID 19389500·Semin Hematol·2009
6-review
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma.
PMID 19509231·Cancer Res·2009
7-preclinical
Independent measurement of the total active 8B solar neutrino flux using an array of 3He proportional counters at the Sudbury Neutrino Observatory.
PMID 18851271·Phys Rev Lett·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7737 SOUTHWEST FWY STE 201
HOUSTON, TX 77074 - Phone
- (713) 776-0655
Quick Facts
- NPI
- 1568775096
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile